Hologic (HOLX) Competitors $61.20 +0.35 (+0.57%) As of 11:00 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HOLX vs. EW, IDXX, RMD, DXCM, STE, PODD, BAX, GMED, MASI, and TFXShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), and Teleflex (TFX). These companies are all part of the "health care equipment" industry. Hologic vs. Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Insulet Baxter International Globus Medical Masimo Teleflex Edwards Lifesciences (NYSE:EW) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, community ranking, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment. Do institutionals & insiders have more ownership in EW or HOLX? 79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 1.9% of Hologic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, EW or HOLX? Edwards Lifesciences has higher revenue and earnings than Hologic. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdwards Lifesciences$5.44B7.48$4.17B$6.979.93Hologic$4.04B3.40$789.50M$3.1719.31 Do analysts rate EW or HOLX? Edwards Lifesciences presently has a consensus target price of $79.95, suggesting a potential upside of 15.47%. Hologic has a consensus target price of $84.62, suggesting a potential upside of 38.25%. Given Hologic's stronger consensus rating and higher possible upside, analysts plainly believe Hologic is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edwards Lifesciences 1 Sell rating(s) 13 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.40Hologic 0 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.41 Does the media prefer EW or HOLX? In the previous week, Hologic had 4 more articles in the media than Edwards Lifesciences. MarketBeat recorded 30 mentions for Hologic and 26 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.50 beat Hologic's score of 1.10 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 24 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive Hologic 20 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer EW or HOLX? Edwards Lifesciences received 456 more outperform votes than Hologic when rated by MarketBeat users. Likewise, 70.85% of users gave Edwards Lifesciences an outperform vote while only 69.32% of users gave Hologic an outperform vote. CompanyUnderperformOutperformEdwards LifesciencesOutperform Votes133770.85% Underperform Votes55029.15% HologicOutperform Votes88169.32% Underperform Votes39030.68% Is EW or HOLX more profitable? Edwards Lifesciences has a net margin of 72.93% compared to Hologic's net margin of 18.42%. Hologic's return on equity of 19.72% beat Edwards Lifesciences' return on equity.Company Net Margins Return on Equity Return on Assets Edwards Lifesciences72.93% 19.40% 14.37% Hologic 18.42%19.72%10.94% Which has more volatility and risk, EW or HOLX? Edwards Lifesciences has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, Hologic has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. SummaryEdwards Lifesciences beats Hologic on 11 of the 19 factors compared between the two stocks. Remove Ads Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicX IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.75B$10.57B$5.17B$7.12BDividend YieldN/A2.01%5.00%4.16%P/E Ratio19.3316.7521.2517.47Price / Sales3.406.68349.9987.93Price / Cash11.6911.9038.1534.64Price / Book2.881.856.153.79Net Income$789.50M$344.53M$3.20B$247.35M7 Day Performance-0.91%-13.70%-1.66%-6.48%1 Month Performance-5.17%-22.14%-4.96%-10.82%1 Year Performance-21.51%-11.85%2.15%-8.06% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.7752 of 5 stars$61.21+0.6%$84.62+38.2%-22.0%$13.75B$4.04B19.336,940Positive NewsEWEdwards Lifesciences4.5046 of 5 stars$72.53+2.3%$79.95+10.2%-25.1%$42.57B$5.44B10.3917,300Positive NewsIDXXIDEXX Laboratories4.067 of 5 stars$420.55+1.1%$533.75+26.9%-24.2%$34.05B$3.90B39.3710,800Analyst UpgradePositive NewsRMDResMed4.3725 of 5 stars$224.17+1.9%$249.73+11.4%+8.5%$32.86B$4.93B26.428,160Insider TradePositive NewsDXCMDexCom4.8657 of 5 stars$68.43+1.0%$99.82+45.9%-56.9%$26.67B$4.03B47.727,600Positive NewsSTESTERIS4.3813 of 5 stars$226.73+1.7%$258.75+14.1%-0.1%$22.25B$5.40B48.0718,179Positive NewsPODDInsulet4.296 of 5 stars$262.25+1.4%$292.06+11.4%+48.6%$18.34B$2.07B45.122,600Positive NewsGap DownBAXBaxter International4.6425 of 5 stars$34.40+1.9%$38.56+12.1%-32.5%$17.57B$10.64B-26.8360,000GMEDGlobus Medical4.9266 of 5 stars$73.28+1.0%$97.09+32.5%+33.1%$10.08B$2.52B97.722,600Positive NewsGap DownMASIMasimo4.1775 of 5 stars$166.96+2.1%$194.80+16.7%+1.3%$8.99B$2.09B114.896,200TFXTeleflex4.3568 of 5 stars$138.36+0.4%$182.63+32.0%-39.1%$6.40B$3.05B27.4215,500Analyst Revision Remove Ads Related Companies and Tools Related Companies Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Globus Medical Alternatives Masimo Alternatives Teleflex Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOLX) was last updated on 4/7/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThinking of buying Nvidia? Read this firstI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.